List View

By /

Clear

Displaying 326 - 350 of 2,995

A Case Presentation in Metastatic Breast Cancer - Opportunities for Immunotherapy

A Case Presentation in Metastatic Breast Cancer - Opportunities for Immunotherapy

HER+, ER+, San Antonio Update

HER+, ER+, San Antonio Update

Non-Clear Cell RCC - Emerging Approaches

Non-Clear Cell RCC - Emerging Approaches

Targeted Therapy

Targeted Therapy

Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020

Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020

Promising Immunotherapy for Melanoma

Promising Immunotherapy for Melanoma

Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK

Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK

Immunotherapy in Lung Cancer

Immunotherapy in Lung Cancer

Lung Targeted Therapies in NSCLC - EGFR, ALK, and ROS1

Lung Targeted Therapies in NSCLC - EGFR, ALK, and ROS1

Case Presentation - GU

Case Presentation - GU

Targeted Therapy in Prostate

Targeted Therapy in Prostate

Immunotherapy in Breast

Immunotherapy in Breast

Lung Cancer Immunotheraphy Case Presentation

Lung Cancer Immunotheraphy Case Presentation

Case Presentation - Breast

Case Presentation - Breast

Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA

Breast Targeted Therapy - HER2, CDK 4-6, PI3KCA

Immunotherapy in Kidney & Bladder

Immunotherapy in Kidney & Bladder

Immunotherapy & Targeted Therapy in Melanoma

Immunotherapy & Targeted Therapy in Melanoma

The New Osteonecrosis Of The Jaws

The New Osteonecrosis Of The Jaws

Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers Part 1

Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers Part 1

Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers Part 2

Updates in Immunotherapy & Targeted Therapy in Gastrointestinal Cancers Part 2

Supportive Care in Oncology - Anemia,Neutropenia, Emesis and Bone Metastases

Supportive Care in Oncology - Anemia,Neutropenia, Emesis and Bone Metastases

Predictive Biomarkers for Immunotherapy - Non-Small Cell Lung Cancer (NSCLC) as a Model of Tumor Heterogeneity

Predictive Biomarkers for Immunotherapy - Non-Small Cell Lung Cancer (NSCLC) as a Model of Tumor Heterogeneity

Other Driver Mutations: ROS-1, RET, HER-2, MET & Exon 20 Insertions

Other Driver Mutations: ROS-1, RET, HER-2, MET & Exon 20 Insertions

Advantages and Disadvantages of VSP in Current Residency Training

Advantages and Disadvantages of VSP in Current Residency Training

Surgical Progression of a Maxillofacial Trauma Patient Sustaining an Industrial Accident

Surgical Progression of a Maxillofacial Trauma Patient Sustaining an Industrial Accident